Soluble CD25/IL-2Rα was also increased 1.8-fold in patients with severe and critical (p<0.001) COVID-19, regarding mild COVID-19, whereas the amount of IL-2 in plasma was reduced 1.5-fold (p<0.05 for critical COVID-19) (Figure 1B). The gene discussed is IL2; the disease is COVID-19.